SCHEMBL8555467

SCHEMBL8555467

N=C(N)NCCCS(=O)(=O)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
F2 P00734 2/20 0.41
PRSS1 P07477 2/20 0.41
PRSS2 P07478 2/20 0.41
PRSS3 P35030 2/20 0.41
POLB P06746 1/20 0.41
CA2 P00918 3/20 0.41
CA1 P00915 2/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8557842 0.95 KMT2A (0.43) KMT2AMEN1HTTKDM4EALDH1A1
SCHEMBL5966775 0.76 CA2 (0.43) KMT2AMEN1HTTALDH1A1PRSS1
SCHEMBL8202834 0.75 L3MBTL1 (0.58) KMT2AHTTKDM4EALDH1A1POLB
[11C]Phenethylguanidine SCHEMBL5461636 0.74 ALDH1A1 (0.64) KDM4EALDH1A1CA2CA1MMP1
SCHEMBL8559623 0.74 HDAC1 (0.50) KMT2AMEN1KDM4EALDH1A1CA2
Hydrochloric Acid SCHEMBL28129395 0.74 L3MBTL1 (0.56) KMT2AMEN1KDM4EPOLBGAA
SCHEMBL21171920 0.74 TRPV1 (0.56) KMT2AALDH1A1LMNA
SCHEMBL8799340 0.73 SLC1A3 (0.49) F2MMP1MMP2MMP9MMP13
Sulfuric Acid SCHEMBL11558166 0.72 EPHX2 (0.44) HTTKDM4EALDH1A1CA2CA1
SCHEMBL8559920 0.72 GAA (0.44) KMT2AHTTPOLBALOX15LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832076-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 EP disclosed